AMI Asset Management’s Genomic Health, Inc. GHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-118,835
Closed -$8.06M 85
2019
Q3
$8.06M Sell
118,835
-25,264
-18% -$1.74M 0.42% 57
2019
Q2
$8.38M Buy
+144,099
New +$8.54M 0.42% 62

AMI Asset Management's GHDX Position: Q4 2019 in Review

AMI Asset Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 118,835 shares — an estimated $8.06M sold.

AMI Asset Management first reported a position in GHDX in Q2 2019 and held it in 2 quarters. The position peaked at $8.38M in Q2 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

  • AMI Asset Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
  • AMI Asset Management sold 118,835 Genomic Health, Inc. shares in Q4 2019, an estimated $8.06M.
  • AMI Asset Management first reported a position in Genomic Health, Inc. in Q2 2019 and held it in 2 quarters.
  • AMI Asset Management's Genomic Health, Inc. position peaked at $8.38M in Q2 2019.
  • 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on AMI Asset Management's 13F filing for Q4 2019, filed 23 Jan 2020.